NCT03248622View on ClinicalTrials.gov

Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection

CompletedOBSERVATIONAL
Enrollment

79

Participants

Timeline

Start Date

June 3, 2017

Primary Completion Date

May 28, 2019

Study Completion Date

May 28, 2019

Conditions
Hepatitis B
Trial Locations (1)

20892

National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK), Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT03248622 - Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection | Biotech Hunter | Biotech Hunter